首页 > 市场调查报告书 > 医疗设备

体外诊断

非侵入性产前检测 (NIPT) 市场规模、份额和成长分析（按产品、检测方法、技术、怀孕风险、怀孕週数、应用和地区划分）：产业预测（2026-2033 年）

市场调查报告书

商品编码

1898007

非侵入性产前检测 (NIPT) 市场规模、份额和成长分析（按产品、检测方法、技术、怀孕风险、怀孕週数、应用和地区划分）：产业预测（2026-2033 年）

Non-Invasive Prenatal Testing (NIPT) Market Size, Share, and Growth Analysis, By Product (Consumables, Reagents), By Testing Method, By Technology, By Pregnancy Risk, By Gestation Period, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球非侵入性产前检测 (NIPT) 市场规模预计在 2024 年达到 41.6 亿美元，从 2025 年的 45.6 亿美元增长到 2033 年的 94.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 9.6%。

由于非侵入性产前检测 (NIPT) 能够透过对母体血液中胎儿游离DNA进行基因分析，检测出常见的染色体异常，例如21三体综合征和18三体综合征，因此全球NIPT市场正经历显着增长。 NIPT的优点包括能够确定胎儿血型和Rh因子，以及由于孕妇群体老化而无创技术趋势。 MaterniT21 PLUS和Harmony等主要厂商正在拓展其产品和服务。儘管不断扩大的医保报销范围和技术进步推动了市场扩张，但训练有素的专业人员短缺和严格的监管等挑战仍然是市场发展的障碍。亚太地区的新兴市场为NIPT的进一步成长和创新提供了机会。

全球无创产前检测 (NIPT) 市场驱动因素

全球非侵入性产前检测 (NIPT) 市场的发展主要得益于先进筛检技术的不断进步，这些技术能够早期、准确地检测胎儿的基因异常。各公司正优先研发创新无创产前诊断工具，并积极建立策略联盟和合作关係，以扩大市场占有率。人类基因定序技术的进步为染色体异常检测领域带来了显着进展。此外，许多国家已采纳非侵入性产前筛检通讯协定来识别染色体异常，这反映出各国越来越重视透过先进的产前检测技术来改善母婴健康。

全球无创产前检测（NIPT）市场面临的限制因素

全球非侵入性产前检测（NIPT）市场面临许多挑战，主要原因是检测费用高昂，导致许多开发中国家难以获得这项服务。例如，在印度，NIPT 的典型价格分布为 350 至 400 美元，这成为其广泛普及的一大障碍。此外，新兴国家大众对遗传疾病风险的认知不足也阻碍了市场成长。这些因素，再加上人均医疗保健支出有限以及检测报销政策不完善，共同阻碍因素着全球 NIPT 市场的发展。

全球无创产前检测（NIPT）市场趋势

全球非侵入性产前检测 (NIPT) 市场正经历显着的趋势转变，非侵入性检测的普及得益于技术进步以及人们对其临床疗效和经济优势的日益认可。随着医疗法规对非侵入性通讯协定的支持力度不断增加，这些检测方法正逐渐成为多个地区产前筛检的标准方法。在荷兰等国家，这种转变尤其明显，非侵入性诊断已成为孕妇的首选。儘管对于某些疾病，侵入性检测仍然至关重要，但非侵入性检测在全球范围内的普及速度仍在持续加快，这反映出整个行业正朝着以患者为中心、更安全的产前护理解决方案转型。

贝瑞基因股份有限公司（中国）
华大基因股份有限公司（中国）
Eurofins LifeCodexx GmbH（德国）
F. Hoffmann-La Roche Ltd.（瑞士）
GE医疗（美国）
Natera公司（美国）
美国实验室控股公司（LabCorp）（美国）
Illumina公司（美国）
Myriad Genetics, Inc.（美国）
Quest Diagnostics Incorporated（美国）
赛默飞世尔科技公司（美国）
Sonic Healthcare Limited（澳洲）
Centogene NV（德国）
珀金埃尔默公司（美国）
Cordlife集团股份有限公司（新加坡）

结论与建议

简介目录

Product Code: SQMIG35J2080

Global Non-Invasive Prenatal Testing (NIPT) Market size was valued at USD 4.16 Billion in 2024 and is poised to grow from USD 4.56 Billion in 2025 to USD 9.49 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The global market for non-invasive prenatal testing (NIPT) is experiencing significant growth as it leverages genetic analysis of fetal cell-free DNA in maternal blood to detect common chromosomal abnormalities like trisomy 21, trisomy 18, and others. Its advantages include the ability to ascertain the fetus's blood type and Rh factor, alongside a trend toward non-invasive methods over invasive procedures due to rising maternal age. Key players in this space, like MaterniT21 PLUS and Harmony, are diversifying offerings. Market expansion is supported by increasing insurance reimbursements and advancements in technology, while challenges such as a shortage of trained professionals and stringent regulations pose obstacles. Emerging markets in the Asia-Pacific region present opportunities for further growth and innovation in NIPT.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Invasive Prenatal Testing (NIPT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Invasive Prenatal Testing (NIPT) Market Segments Analysis

Global Non-Invasive Prenatal Testing (NIPT) Market is segmented by Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User and region. Based on Product, the market is segmented into Consumables, Reagents and Instruments. Based on Testing Method, the market is segmented into Ultrasound Detection, Biochemical Screening Tests and Cell-Free DNA in Maternal Plasma Tests. Based on Technology, the market is segmented into NGS, Array Technology, PCR and Others. Based on Pregnancy Risk, the market is segmented into High Risk, Average Risk and Low Risk. Based on Gestation Period, the market is segmented into 0-12 Weeks, 13-24 Weeks and 25-36 Weeks. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Invasive Prenatal Testing (NIPT) Market

The Global Non-Invasive Prenatal Testing (NIPT) market is driven by the continuous advancement of highly sophisticated screening techniques that ensure early and accurate detection of genetic abnormalities in fetuses. Companies are prioritizing the development of innovative noninvasive prenatal diagnostic tools and are engaging in strategic partnerships and collaborations to enhance their market presence. Notable progress in detecting aneuploidies has been bolstered by advancements in human genome sequencing. Additionally, various countries are adopting non-invasive prenatal screening protocols aimed at identifying chromosomal abnormalities, reflecting a growing emphasis on improving maternal and fetal health outcomes through advanced technology in prenatal testing.

Restraints in the Global Non-Invasive Prenatal Testing (NIPT) Market

The Global Non-Invasive Prenatal Testing (NIPT) market faces significant challenges primarily due to the high costs associated with these tests, which render them inaccessible in many developing countries. For instance, in India, the typical price range for NIPT can be between USD 350 and USD 400, creating barriers to widespread adoption. Additionally, a general lack of awareness regarding genetic disorder risks among populations in emerging nations further hinders growth. Compounding these issues are factors such as limited per capita healthcare expenditure and inadequate reimbursement policies for testing, all of which contribute to the constraints faced by the NIPT market on a global scale.

Market Trends of the Global Non-Invasive Prenatal Testing (NIPT) Market

The Global Non-Invasive Prenatal Testing (NIPT) market is witnessing a significant trend towards non-invasive examinations driven by advancements in technology and the heightened awareness of their clinical efficacy and economic advantages. As healthcare regulations increasingly favor non-invasive protocols, these testing methods are becoming standard practice for prenatal screenings in various regions. The shift is particularly notable in countries like the Netherlands, where non-invasive diagnostics have become the primary option for pregnant women. Despite the remaining relevance of invasive tests for specific conditions, the global uptake of non-invasive testing continues to accelerate, reflecting a broader industry transformation towards patient-friendly and safer prenatal care solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables
Reagents
Instruments

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Testing Method & CAGR (2026-2033)

Market Overview
Ultrasound Detection
Biochemical Screening Tests
Cell-Free DNA in Maternal Plasma Tests

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Technology & CAGR (2026-2033)

Market Overview
NGS
Array Technology
PCR
Others

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Pregnancy Risk & CAGR (2026-2033)

Market Overview
High Risk
Average Risk
Low Risk

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Gestation Period & CAGR (2026-2033)

Market Overview
0-12 Weeks
13-24 Weeks
25-36 Weeks

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Application & CAGR (2026-2033)

Market Overview
Trisomy
Microdeletion Syndrome
Others

Global Non-Invasive Prenatal Testing (NIPT) Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Diagnostic Laboratories
Others

Global Non-Invasive Prenatal Testing (NIPT) Market Size & CAGR (2026-2033)

North America (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- US
- Canada
Europe (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Berry Genomics Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins LifeCodexx GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Centogene N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordlife Group Limited (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments